|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Department of Surgery, John D. Dingell VA Medical Center and Wayne State University, Detroit, Michigan, USA
1Correspondence: Surgical Service, John D. Dingell VA Medical Center, 4646 John R. St., Detroit, Michigan 48201-1932, USA. E-mail: marc.basson{at}va.gov
Cancer cell adhesion is traditionally viewed as random, occurring if the cells receptors match the substrate. Cancer cells are subjected to pressure and shear during growth against a constraining stroma, surgical manipulation, and passage through the venous and lymphatic system. Cells shed into a cavity such as the abdomen postoperatively also experience increased pressure from postoperative edema. Increased extracellular pressure stimulates integrin-mediated cancer cell adhesion via FAK and Src. PI 3-kinase (PI3K) inhibitors (LY294002 or wortmannin), Akt inhibitors, or Akt1 siRNA blocked adhesion stimulated by 15 mmHg pressure in SW620 or primary human malignant colonocytes. Pressure activated PI3K, tyrosine-phosphorylated and membrane-translocated the p85 subunit, and phosphorylated Akt. PI3K inhibitor (LY294002) prevented pressure-stimulated Akt Ser473 and FAK Tyr397, but not FAK576 or Src416 phosphorylation. PP2 inhibited PI3K activity and Akt phosphorylation. FAK siRNA did not affect pressure-induced PI3K activation but blocked Akt phosphorylation. Pressure also stimulated FAK or FAKY397F mutant translocation to the membrane. Akt inhibitor IV blocked pressure-induced Akt and FAK translocation. Pressure activated Src- and PI3K-dependently induced p85 interaction with FAK, and FAK with ß1 integrin. These results delineate a novel force-activated inside-out Src/PI3K/FAK/Akt pathway by which cancer cells regulate their own adhesion. These signals may be potential targets for inhibition of metastatic adhesion.Thamilselvan V., Craig D. H., Basson M. D. FAK association with multiple signal proteins mediates pressure-induced colon cancer cell adhesion via a Src-dependent PI3K/Akt pathway.
Key Words: integrin affinity membrane translocation p85 subunit Akt isoforms physical forces mechanotransduction
This article has been cited by other articles:
![]() |
K. E. Michael, D. W. Dumbauld, K. L. Burns, S. K. Hanks, and A. J. Garcia Focal Adhesion Kinase Modulates Cell Adhesion Strengthening via Integrin Activation Mol. Biol. Cell, May 1, 2009; 20(9): 2508 - 2519. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. Gayer, L. S. Chaturvedi, S. Wang, B. Alston, T. L. Flanigan, and M. D. Basson Delineating the signals by which repetitive deformation stimulates intestinal epithelial migration across fibronectin Am J Physiol Gastrointest Liver Physiol, April 1, 2009; 296(4): G876 - G885. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. Gayer, L. S. Chaturvedi, S. Wang, D. H. Craig, T. Flanigan, and M. D. Basson Strain-induced Proliferation Requires the Phosphatidylinositol 3-Kinase/AKT/Glycogen Synthase Kinase Pathway J. Biol. Chem., January 23, 2009; 284(4): 2001 - 2011. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Craig, C. P. Gayer, K. L. Schaubert, Y. Wei, J. Li, Y. Laouar, and M. D. Basson Increased extracellular pressure enhances cancer cell integrin-binding affinity through phosphorylation of {beta}1-integrin at threonine 788/789 Am J Physiol Cell Physiol, January 1, 2009; 296(1): C193 - C204. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Evans, Z. Nasim, J. Brown, E. Clapp, A. Amin, B. Yang, T. P. Herbert, and A. Bevington Inhibition of SNAT2 by Metabolic Acidosis Enhances Proteolysis in Skeletal Muscle J. Am. Soc. Nephrol., November 1, 2008; 19(11): 2119 - 2129. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Basson An Intracellular Signal Pathway That Regulates Cancer Cell Adhesion in Response to Extracellular Forces Cancer Res., January 1, 2008; 68(1): 2 - 4. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Im and A. Kazlauskas Src Family Kinases Promote Vessel Stability by Antagonizing the Rho/ROCK Pathway J. Biol. Chem., October 5, 2007; 282(40): 29122 - 29129. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |